Author response to Dr. Aziz-"Statin use and delayed onset of Huntington disease"
Mov Disord
.
2019 May;34(5):763-764.
doi: 10.1002/mds.27678.
Authors
Jordan L Schultz
1
2
3
,
Peg C Nopoulos
1
2
4
,
Annie Killoran
2
5
,
Amy Ogilvie
6
,
John A Kamholz
1
2
Affiliations
1
Carver College of Medicine at the University of Iowa, Department of Psychiatry, Iowa City, Iowa, USA.
2
Carver College of Medicine at the University of Iowa, Department of Neurology, Iowa City, Iowa, USA.
3
The University of Iowa College of Pharmacy, Department of Pharmacy Practice and Science, Iowa City, Iowa, USA.
4
Stead Family Department of Pediatrics at the University of Iowa, Iowa City, Iowa, USA.
5
The Veteran's Affair Medical Center of Iowa City, Iowa City, Iowa, USA.
6
The University of Iowa College of Public Health, Department of Epidemiology, Iowa City, Iowa, USA.
PMID:
31091359
PMCID:
PMC6521849
DOI:
10.1002/mds.27678
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Huntington Disease*
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Grants and funding
P01 HL046925/HL/NHLBI NIH HHS/United States
UG3 HL143204/HL/NHLBI NIH HHS/United States
R01 DE014399/DE/NIDCR NIH HHS/United States
R01 NS094387/NS/NINDS NIH HHS/United States
R01 NS055903/NS/NINDS NIH HHS/United States
KL2 TR002536/TR/NCATS NIH HHS/United States